Progestin-only pill (mini-pill)

The progestin-only pill (POP), often called the mini-pill, contains a synthetic progestin without estrogen. Common formulations include norethindrone (the classic mini-pill) and drospirenone (Slynd, the newer option). It is taken every day with no placebo week.

The mini-pill is most often prescribed for users who cannot take estrogen, including those who are breastfeeding, over 35 and smoking, or have a history of clots or migraine with aura.

This is informational, not medical advice. Contraceptive choice should be discussed with a qualified provider.

How it works

The mini-pill works through three overlapping effects, with the balance depending on the formulation:

  1. Cervical mucus thickening. This is the dominant effect for the classic norethindrone mini-pill. It reduces sperm penetration.
  2. Partial ovulation suppression. Norethindrone suppresses ovulation in roughly 40 to 60% of cycles. Drospirenone suppresses it in roughly 97% of cycles, much closer to the combined pill.
  3. Endometrial thinning. Reduces implantation receptivity.

The strict 3-hour dosing window of the norethindrone mini-pill exists because its cervical-mucus effect wears off quickly. Drospirenone has a 24-hour window with a 4-hour grace period.

Cycle implications

The mini-pill's cycle effects are formulation-dependent and individual-dependent.

  • On drospirenone: the cycle is suppressed similarly to the combined pill. Ovulation rarely happens, so cycle syncing by phase does not meaningfully apply.
  • On norethindrone: ovulation happens in roughly half of cycles. Some users still have a recognizable follicular and luteal phase pattern; others do not.

Bleeding patterns on the mini-pill are notoriously unpredictable:

  • Some users have regular monthly bleeds.
  • Some have irregular spotting throughout the month.
  • Some stop bleeding entirely (amenorrhea), which is medically safe but disconcerting.

For users who do still ovulate on the mini-pill, ovulation tracking (via BBT or OPK) is the only reliable way to know when phases are happening.

Common side effects

  • Irregular bleeding or spotting, especially in the first three months.
  • Breast tenderness and mood changes.
  • Acne or oilier skin with norethindrone (mild androgenic activity); drospirenone tends to be neutral or anti-androgenic.
  • Headaches.
  • Ovarian cysts (functional, usually resolving on their own).

The mini-pill avoids the estrogen-related risks of CHCs (blood clots, stroke), which is the main reason it gets prescribed.

When to consider

  • Breastfeeding (estrogen reduces milk supply, progestin alone does not).
  • History of clots, stroke, or migraine with aura.
  • Smoker over 35.
  • High blood pressure or other CHC contraindications.
  • Preference for a daily pill without an estrogen load.

When NOT to consider

  • Difficulty taking a pill at the same time daily (the 3-hour norethindrone window is unforgiving).
  • History of certain breast cancers.
  • Liver disease.
  • Severe unexplained vaginal bleeding before workup.

For users who want progestin-only contraception without the daily-pill compliance burden, the hormonal IUD or contraceptive implant are common alternatives.